Isoform-Selective and Stereoselective Inhibition of Hypoxia Inducible Factor-2

详细信息    查看全文

• 作者：Thomas H. Scheuermann ; Daniel Stroud ; Christopher E. Sleet ; Liela Bayeh ; Cameron Shokri ; Hanzhi Wang ; Charles G. Caldwell ; Jamie Longgood ; John B. MacMillan ; Richard K. Bruick ; Kevin H. Gardner ; Uttam K. Tambar
• 刊名：Journal of Medicinal Chemistry
• 出版年：2015
• 出版时间：August 13, 2015
• 年：2015
• 卷：58
• 期：15
• 页码：5930-5941
• 全文大小：675K
• ISSN：1520-4804

文摘

Hypoxia inducible factor (HIF) transcription factors reside at the center of signaling pathways used by mammalian cells to sense and respond to low oxygen levels. While essential to maintain oxygen homeostasis, misregulation of HIF protein activity correlates with tumor development and metastasis. To provide artificial routes to target misregulated HIF activity, we identified small molecule antagonists of the HIF-2 transcription factor that bind an internal cavity within the C-terminal PAS domain of the HIF-2伪 subunit. Here we describe a new class of chiral small molecule ligands that provide the highest affinity binding, the most effective, isoform-selective inhibition of HIF-2 in cells, and trigger the largest protein conformation changes reported to date. The current results further illuminate the molecular mechanism of HIF-2 antagonism and suggest additional routes to develop higher affinity and potency HIF-2 antagonists.